Nationals Trade Brad Hand To Blue Jays
The Blue Jays have added another arm to their bullpen mix, announcing the acquisition of veteran lefty Brad Hand from the Nationals in exchange for catcher Riley Adams. Hand, who signed a one-year, $10.5MM deal with the Nats this past offseason, will be a free agent at season’s end.
Hand, 31, has been one of the game’s most effective left-handed relievers in recent years, but his results in 2021 haven’t been as dominant as they were during his time with the Padres and Indians. There have been some signs that his stock had dipped in the eyes of those around the game; Cleveland put him on outright waivers at the end of the 2020 season, hoping a club would claim him and pick up his $10MM option — thus sparing the Indians the $1MM buyout. He went unclaimed and was ultimately bought out. Hand did eventually land a greater guarantee, signing at that aforementioned $10.5MM price point.
Some of the reservations regarding Hand when he was placed on waivers were simply due to financial uncertainty following the absence of fans in 2020, but there was also concern that the lefty’s fastball had dropped by two miles per hour from its peak level. He’s alleviated those concerns in 2021, tacking two miles back onto his heater and averaging 93.3 mph on the season. But Hand’s 23.3 percent strikeout rate is his lowest since moving from the rotation to the bullpen back in 2016, and his 9.9 percent walk rate is a career-high (as a reliever).
Those ungainly strikeout/walk trends notwithstanding, Hand has been a solid reliever for much of the season in Washington. He’s pitched to a 3.59 ERA, upped his ground-ball rate to its highest level since 2018 (39.5 percent) and generally limited hard contact and barreled balls quite well, per Statcast.
It’s been a tough go more recently, as Hand has served up eight runs in his past nine innings — three of which came on an Andrew McCutchen walk-off home run that proved to be something of a backbreaker for the reeling Nationals. Not long after dropping that pivotal game, rumblings about the Nationals perhaps engineering a rare (for them) summer sell-off began to pick up steam, and Hand’s departure (plus the persistent rumors on Max Scherzer and other prominent Nationals players) now make that speculation a reality.
For their half-season investment in Hand, the Nationals will acquire Adams, a 25-year-old backstop who’s already made a very brief MLB debut. That didn’t go particularly well, as he hit just .107/.167/.179, but he also received only 30 plate appearances with the Jays, so it’s impossible to glean much of anything from that limited sample. Adams has spent the remainder of the 2021 season with the Jays’ Triple-A affiliate, drawing plenty of walks and hitting for good power but struggling with strikeouts. In 143 plate appearances, he’s hitting .237/.371/.487 with an 11.2 percent walk rate but a lofty 32.2 percent strikeout rate.
Adams ranked 20th among Jays prospects heading into the season over at MLB.com. He’s already been bumped to No. 15 among Nationals prospects over at FanGraphs, where Eric Longenhagen calls him a bat-first backup option behind the plate. Adams, listed at 6’4″ and 246 pounds, is quite large for a catcher, but the Jays have been committed to developing him there. He’s appeared in just one professional game at first base, where he logged only three innings. If Adams proves he’s capable of sticking behind the dish and providing passable defense, he’ll greatly outperform many of the more modest value projections most scouting reports have placed on him due to concerns over his size and glovework.
Jesse Dougherty of the Washington Post first reported Hand had been traded to the Jays (Twitter thread). USA Today’s Bob Nightengale reported Adams was going back to the Nats.
Nationals Place Daniel Hudson, Trea Turner On Covid IL
The Nationals announced this morning that they’ve placed shortstop Trea Turner, right-hander Daniel Hudson, righty Austin Voth and catcher Alex Avila on the Covid-19-related injured list prior to today’s doubleheader. They’ve also reinstated catcher Yan Gomes and righty Tanner Rainey from the 10-day injured list in a pair of corresponding moves. Additionally, right-hander Andres Machado and infielder Luis Garcia were recalled from Triple-A Rochester.
Turner hitting the Covid IL was a foregone conclusion after he tested positive a couple days ago. It wasn’t yet clear which other players might need to be placed on the Covid-related list until today, however. To be clear, the Nationals did not reveal whether any of Hudson, Voth or Avila had tested positive or whether they were close contacts.
Turner and Hudson, notably, have emerged as a trade candidates as the Nationals’ recent slide in the standings has caused the team to pivot to sellers. Both players can still be traded while on the Covid-19 list, though their current status obviously complicates any potential discussions. A player who tests positive is subject to a minimum 10-day quarantine under MLB’s 2021 health and safety protocols; close contacts are subject to seven-day quarantines.
Joel Sherman of the New York Post reported yesterday that even in the wake of Turner’s positive test, he was still drawing interest (Twitter thread). At least two executives to whom Sherman spoke believed a trade involving Turner would still come together, though that’s still far from a given. Even prior to Tuesday’s positive test, Turner represented a difficult player to pry away. The All-Star shortstop is earning $13MM in 2021 and has another year of arbitration remaining, making him costly in terms of both salary and prospects. The Athletic’s Jim Bowden wrote this morning that a trade was unlikely, noting that several interested parties prefer to look at alternative options and wait until free agency this offseason to pursue one of the many high-end shortstops available in free agency (e.g. Carlos Correa, Corey Seager, Marcus Semien, Javier Baez, Trevor Story).
As for Hudson, he’s an impending free agent who has somewhat quietly been having the best season of his 12-year big league career. The 34-year-old, who closed out the World Series for the Nationals in 2019, has pitched to a 2.20 ERA with a career-high 37.5 percent strikeout rate and a 5.5 percent walk rate that nearly matches his 5.4 percent career-low. He’s earning $6MM in 2021, and while Hudson doesn’t carry the name value of some more notable targets like Craig Kimbrel or even his own teammate, Brad Hand, he’s among the best relief options on the market.
Phillies – Nationals Game Postponed Due To COVID Issues
5:05 pm: There are twelve total positive cases, manager Dave Martinez told reporters (including Jesse Dougherty of the Washington Post). Those are four players (including Turner) and eight staff members. Eleven of the twelve have been vaccinated, according to Martinez. Fortunately, no one involved feels seriously ill, which the skipper attributed to the high vaccination rate among those infected.
MLB has tentatively scheduled a doubleheader tomorrow to make up tonight’s game. That, of course, is pending additional follow-up testing.
4:34 pm: Tonight’s game between the Phillies and Nationals has been postponed due to positive COVID-19 tests within the Washington organization, Jeff Passan of ESPN was among those to report. “Multiple players and coaches” with the club have tested positive, according to Passan, who suggests the current outbreak might be the most significant MLB has seen in 2021. Ken Rosenthal of the Athletic first reported the game might be in jeopardy.
Star shortstop Trea Turner was pulled from last night’s game after testing positive, and follow-up testing today revealed further spread among the club. The teams are scheduled to play tomorrow evening, although it certainly seems possible that game could also be in jeopardy given Passan’s report of multiple people now afflicted with the virus. Notably, tomorrow evening’s game is Max Scherzer’s final scheduled start before the trade deadline.
Washington is one of the teams to have crossed the 85% vaccination threshold for Tier 1 personnel, Mark Zuckerman of MASNsports.com was among those to note. The Nationals also dealt with COVID spread at the beginning of the season, forcing the postponement of the first four games of their season.
Latest On Max Scherzer
As of last night, there were at least eight clubs interested in Nationals ace Max Scherzer, who is open to waiving his no-trade rights but said to have a preference for a West Coast club that has the ability to keep him longer-term.
Scherzer figures to be one of the most talked-about trade candidates in recent memory, but his stay on the market may not go down to the wire like some other stars. The Athletic’s Ken Rosenthal reports that the Nationals want to get a framework for a trade in place as quickly as possible, in order to leave enough time to work out the details surrounding Scherzer’s no-trade rights and any compensation he’d require to waive them. MLB.com’s Jon Morosi tweets that some involved in negotiations believe an agreement could come together by tonight.
While Scherzer has been connected to more than a quarter of the league, Rosenthal and Morosi both suggest that the three NL West contenders — the Padres, Dodgers and Giants — are the likeliest destinations at this time. MLB.com’s Mark Feinsand suggested something similar yesterday. Both SNY’s Andy Martino and The Athletic’s Jayson Stark, meanwhile, have indicated that Scherzer would not approve a trade to either New York club.
Any of the three NL West contenders make for a sensible landing spot. The Giants hold the best record in Major League Baseball and ought to be motivated to aggressively strengthen their club down the stretch. The Dodgers’ rotation strength has dwindled since the season began, and the Padres are without several key rotation options themselves at the moment.
Of the bunch, only the Giants could acquire Scherzer without incurring any luxury-tax penalization. Scherzer’s deferral-heavy contract comes with an annual luxury hit of just under $30MM, and the prorated remainder of that hit as of this writing would be $10.49MM. (It’d drop to $10.03MM after the deadline.) The Dodgers, already in the top tax bracket for year-one offenders, would pay a 62.5 percent tax on that $10.03MM overage. The Padres are barely over the threshold at the moment and exploring some ambitious ways to drop back below the barrier; at the moment, they’d pay a 20 percent overage penalty.
Scherzer, who turned 37 yesterday, has pitched to a 2.83 ERA with a 35.1 percent strikeout rate (tying a career-high) and a 4.2 percent walk rate in 105 innings this year. He’s playing on a $35MM salary this year in the final season of a seven-year, $210MM contract, though the bulk of that 2021 salary is deferred to 2028. Schezer was scratched from his Saturday start against the Orioles due to a triceps issue, though the Nationals have indicated that an MRI came back clean. He’s listed as the probable starter for Thursday’s game against the Phillies. Of course, that recent health scare only muddies the water as teams try to put together a framework with the Nats.
At Least Eight Teams In The Mix For Max Scherzer
As many as eight clubs are in the mix for Nationals ace and three-time Cy Young winner Max Scherzer, per Jayson Stark of The Athletic (Twitter link). The Dodgers, Giants, Padres, Red Sox, Rays, Blue Jays, Astros and Mets are all interested, according to Stark, who adds that the Yankees also inquired but were told Scherzer isn’t likely to waive his no-trade rights for a move to New York. That meshes with recent reporting from SNY’s Andy Martino, who wrote earlier this afternoon that Scherzer wouldn’t approve a trade to the Mets (nor would the Nationals be keen on dealing their ace to the current division leaders).
MLB.com’s Mark Feinsand reported earlier in the day that Scherzer preferred a West Coast club, though MLB Network’s Jon Heyman adds that the ostensible West Coast preference is more about Scherzer wanting to go to a team with a chance to win in 2021 and beyond. Scherzer prefers to go to “a team he could stay with” on a possible extension, per Heyman. Agent Scott Boras indicated as much earlier in the summer, although at the time Boras suggested an extension might be necessary in order for Scherzer to waive his no-trade protection at all. That no longer seems to be the case, but as evidenced by Scherzer’s unwillingness to go to a New York club, the no-trade rights can help him choose his eventual landing spot.
If the Nats are to ultimately trade Scherzer, tweets Ken Rosenthal of The Athletic, the team’s preference is to do so within the next 48 hours. Doing so would leave ample time to sort through the no-trade obstacles and any potential compensation for waiving those rights (e.g. alterations to deferrals, taxes, etc.).
That said, a trade taking place prior to Thursday’s game would put an acquiring team in a tough spot. Scherzer was scratched from his weekend start due to a triceps issue and is set to return to the mound Thursday. A recent MRI came back clean, and any team acquiring Scherzer would obviously have access to the results from that imaging and other testing. Still, a clean MRI may not inspire as much confidence as seeing Scherzer go out and actually perform. If interested clubs prefer to wait until Scherzer has taken the mound, there’d be fewer than 24 hours between the conclusion of Thursday’s start and Friday afternoon’s deadline.
Any trade involving Scherzer is going to be financially complicated, but looking at Stark’s list of interested parties, there are a few particularly complex scenarios. The Dodgers are already into the final luxury-tax bracket, meaning they’d pay a 62.5 percent overage penalty on any additional money added to the books. For Scherzer, whose remaining luxury hit clocks in at roughly $10.03MM post-deadline and $10.49MM as of this writing, that’d mean paying between $6.27MM and $6.56MM on top of the approximately $12.2MM he’s still owed in actual 2021 salary. (Luxury tax is calculated based on a contract’s average annual value, but Scherzer’s backloaded contract comes with a $35MM salary in 2021 — albeit with much of that sum deferred.)
The Padres are reportedly just above the luxury tax threshold, but are still considering moves that could take them back under that line. A Scherzer acquisition, however, would push them well above the mark. That’s also true of the Astros and the Red Sox, who are both within just a few million of the $210MM threshold. The Rays, of course, have an entirely different sort of financial obstacles to consider (namely, their perennially cellar-level payroll). The Jays and Giants, as teams with deep pockets and no real luxury concerns of which to speak, ostensibly represent the “cleanest” fits of the bunch.
That’s not to say that the Dodgers, Padres, Astros, Rays or Red Sox shouldn’t be considered legitimate contenders for Scherzer. (Although if Scherzer is hoping to stay with the club that acquires him, the low-payroll Rays are an admittedly tough fit.) Most clubs this summer have voiced some iteration of a “we’d exceed the threshold for the ‘right’ player” stance. It’s hard to imagine a player who fits that billing more than a bona fide ace and three-time Cy Young winner who has a 2.92 ERA in 49 1/3 postseason innings with the Nats since 2016. But with the Nats theoretically negotiating with a rapidly ticking clock, any complicated financial elements of a deal are magnified.
Trea Turner Tests Positive For COVID-19
Nationals star shortstop Trea Turner has tested positive for COVID-19, the team announced. Turner was removed from this evening’s game against the Phillies in the first inning after the result came in. Fellow infielder Luis Garcia is likely to be recalled from Triple-A Rochester to replace Turner on the active roster, reports Jesse Dougherty of the Washington Post (Twitter link).
It’s a shocking development for a player who recently surfaced in trade rumors. Upon Turner’s mid-game exit, plenty of speculation emerged about a potential deal being in the works. Instead, his removal is a result of a positive test.
Placement on the COVID IL doesn’t come with a minimum stint, although the fact that Turner tested positive suggests he’s likely to miss at least ten days while quarantining. Players on the injured list can still be traded, so tonight’s news doesn’t entirely eliminate the possibility of a midseason deal.
That always seemed a bit unlikely, though, given Turner’s star play and the Nationals’ desire to compete again in 2022 (and perhaps to not throw in the towel on the 2021 season). Uncertainty about his health status only figures to complicate any trade talks, casting even more doubt on the possibility of Turner changing teams by Friday.
Obviously, Turner’s health is of paramount importance. The Nationals haven’t offered further comment beyond the news of his positive test result, but it’s notable that Turner felt well enough to take the field tonight before his positive test became known to the organization.
Stephen Strasburg To Undergo Thoracic Outlet Surgery
Nationals righty Stephen Strasburg will undergo surgery to alleviate neurogenic thoracic outlet syndrome, manager Dave Martinez announced to reporters Tuesday (Twitter link via MASNsports.com’s Mark Zuckerman). The procedure will end his season, and the Nationals’ hope is that he can be ready for the start of the 2022 campaign. Martinez’s announcement was a bit more specific than most announcements on TOS surgery, but for those wondering, “neurogenic” thoracic outlet syndrome is the most common of three variations of the ailment, per the Mayo Clinic.
It’s yet another health setback for one of the game’s most talented but also most oft-injured pitchers. Strasburg’s 2020 season also ended with surgery — that one to alleviate carpal tunnel syndrome — and he’ll now head into the 2022 campaign with just 26 2/3 innings under his belt since signing a franchise-record seven-year, $245MM contract as a free agent in the 2019-20 offseason.
Thoracic outlet surgery is more ominous than the more-common Tommy John surgery, as pitchers generally have a much worse track record in returning from TOS operations. That said, Strasburg need look no further than D-backs righty Merrill Kelly to find a recent example of a pitcher who has come back from a TOS procedure as good as ever (arguably better, in Kelly’s case). Former Royals/Padres/Mets righty (and current Rangers GM) Chris Young also attributed TOS surgery to saving his career. Other success stories include former Cardinals hurlers Chris Carpenter and Jaime Garcia.
On the other side of the coin, TOS has proven quite difficult to bounce back from for a number of pitchers around the league. Matt Harvey is the most well-known example, but we’ve also seen thoracic outlet syndrome derail the careers of Tyson Ross, Phil Hughes and Nate Karns, among many others. Chris Archer‘s return from thoracic outlet surgery in 2021 hasn’t gone well, as he pitched just 4 1/3 innings for the Rays before going down with a forearm issue.
Every case is unique to the pitcher in question, of course, so historical precedent only tells us so much. Strasburg is still signed another five years, so the Nats will need to hold out particularly strong hope that he’s able to work back from this and return to something approximating his prior levels of performance. He and Patrick Corbin are both locked into hefty salaries in 2022, and the Nats will also have Joe Ross, Austin Voth, Erick Fedde and Paolo Espino as in-house rotation options. Still, Max Scherzer is set to reach free agency this winter — and could be traded this week — and Strasburg’s health is again up in the air; long-term starting pitching help seems likely to be a focal point for the Nationals both this winter and in the hours leading up to Friday afternoon’s trade deadline.
Max Scherzer Open To Waiving No-Trade Rights
3:45pm: Scherzer would not approve a trade to the Mets, reports SNY’s Andy Martino, nor would the Nationals be open to trading Scherzer to the current NL East leaders.
8:41am: If Scherzer is to waive his no-trade clause, the right-hander “strongly prefers the West Coast,” a source tells MLB.com’s Mark Feinsand. This would naturally favor the Giants, Padres, and Dodgers, while such AL West clubs as the Angels, Athletics, or Mariners couldn’t be ruled out.
July 27, 7:34am: The Athletic’s Ken Rosenthal has some details on Scherzer’s complex contract situation, as Scherzer’s deal contains a lot of deferred money. The roughly $11.8MM remaining of Scherzer’s $35MM salary for 2021 is entirely deferred until 2028, so a new team wouldn’t have to pay that money out for seven years. However, Scherzer’s luxury tax number would be around the $10MM mark, which is certainly a factor for teams trying to avoid a tax payment. Scherzer has another $7.5MM in signing bonus money due this September, but Rosenthal notes that this bonus payment “is solely the Nationals’ obligation.”
July 26: Nationals ace Max Scherzer has been one of the most intriguing trade candidates in baseball as the Nationals have slid down the standings following a scorching month of June, but a trade surrounding him is also complicated for myriad reasons. He’s being paid $35MM in 2021 and has more than $100MM in deferred money still owed to him from 2022-28. The Nationals, historically, do not operate as sellers under general manager Mike Rizzo. Scherzer has full no-trade protection as a 10-and-5 player (10 years of MLB service, the past five with the same team). Additionally, agent Scott Boras has previously suggested that Scherzer would require some type of incentive (e.g. a contract extension) in order to waive those rights.
It would seem that at least one of those major hurdles, however, is surmountable. Jesse Dougherty of the Washington Post reports (via Twitter) that Scherzer is open to being traded and would not invoke his 10-and-5 rights for the sole purpose of remaining with the Nationals. However, Scherzer could use that full no-trade protection as a way to have a say in his ultimate destination if the Nats are presented with offers from multiple clubs.
It’s not yet clear whether the Nationals are going to legitimately make Scherzer available, although a weekend sweep at the hands of a 34-64 Orioles club couldn’t have helped convince Rizzo and his staff that the Nats need to operate as a buyer. Rizzo said just under a week ago that he was approaching the deadline with a both a “buy” and “sell” mindset, remaining open to all possibilities depending on how his team played. The implication was that with a strong showing, the Nats would act as they tend to do under Rizzo: make at least incremental upgrades in an effort to push toward the postseason.
That hasn’t happened, however. The Nats are 1-4 since those comments from Rizzo, including the sweep in Baltimore, and the fact that the Nationals had to slow Stephen Strasburg‘s throwing program down once again only adds another negative element to the equation. Washington now finds itself eight games below .500, seven and a half back of the division lead and 11 out in the Wild Card hunt. The generally feeble nature of the NL East and the top-heavy trio of contenders in the NL West mean that the only path for an NL East club to reach the postseason is likely via a division title. FanGraphs gives the Nats a 1.4 percent chance of making the playoffs; PECOTA is only marginally better, at an even 2.0 percent.
If the Nats do indeed make Scherzer available, he’d (obviously) be the best starting pitcher on a market that is lacking in impact arms. The three-time Cy Young winner and eight-time All-Star, who turns 37 tomorrow, has pitched to a 2.83 ERA with a brilliant 35.1 percent strikeout rate and a 6.1 percent walk rate in 105 innings this season. He’s had one astonishing meltdown that the Padres and Daniel Camarena will never forget, wherein Scherzer allowed 12 percent of the runs he’s yielded all season on one pitch to a just-called-up relief pitcher. Outside of that night, Scherzer has allowed 26 runs in 101 1/3 innings of work (2.31 ERA). He’s held opponents to two or fewer runs in 14 of his 18 starts.
It’s also worth noting that Scherzer had his Saturday start against the Orioles scratched due to discomfort in his right triceps. The injury popped up when he was taking batting practice, not pitching and Scherzer has already said publicly that he plans to make his next start. He underwent an MRI that came back clean, and (via MASNsports.com’s Mark Zuckerman), manager Dave Martinez said Scherzer’s bullpen session today went as planned. Assuming he feels fine tomorrow, he’d be in line to start Thursday’s game for the Nationals — their final game prior to Friday afternoon’s trade deadline.
NL East Notes: Rodriguez, Marchan, Phils, Braves, Kieboom
The Phillies are known to have interest in Pirates reliever Richard Rodriguez, and Jim Salisbury of NBC Sports Philadelphia reports (Twitter link) that catcher Rafael Marchan has been part of the trade talks between the two Pennsylvania clubs. Marchan is ranked fourth on MLB Pipeline’s list of Philadelphia’s top 30 prospects, though Marchan has been mentioned as a possible trade candidate ever since J.T. Realmuto re-signed with the club. Marchan has received a bit of big league playing time in each of the last two seasons but only made his Triple-A debut in 2021, hitting an underwhelming .200/.285/.215 over 151 plate appearances. The 22-year-old also missed a good chunk of Spring Training due to a hamstring injury.
The Phillies lead all of baseball with 23 blown saves, though Ranger Suarez has pitched well and more or less supplanted Hector Neris as the primary closer in recent weeks. Since Suarez’s four saves this season represent his entire career total, acquiring a more proven ninth-inning hurler (though Rodriguez himself only became a full-time closer this season) would go a long way towards solving one of the Phillies’ weaknesses.
More from the NL East…
- The Braves haven’t yet made any move towards being deadline sellers, as ESPN.com’s Buster Olney (via Twitter) reports that Atlanta is still looking to add players. After splitting a doubleheader with the Mets yesterday, the Braves are 49-51 and five games behind division-leading New York, with the Phillies now sitting between the two teams in second place. Atlanta has three games remaining in their series with the Mets, so it isn’t a stretch to say that this series could decide the Braves’ season.
- The Nationals could be open to trades for almost anyone on their roster, though Carter Kieboom may not be available, as FanSided’s Robert Murray reports that the Nats recently declined to discuss the infielder with an interested team. Specifically, the suitor was told that Washington wouldn’t discuss a Kieboom trade “right now,” so while this could technically mean that the Nationals might willing to talk now that they’re more directly looking to sell, Murray figures the Nats aren’t likely to move one of their younger and more promising players. While Kieboom has struggled over 173 PA in the majors, the 23-year-old isn’t far removed from being considered one of baseball’s top prospects.
Nats Receiving Strong Interest In Trea Turner
TODAY: Beyond Turner, the Nationals are willing to at least discuss trading anyone besides Juan Soto, according to Dan Federico (Twitter link).
JULY 26: It’s been less than a week since Nationals GM Mike Rizzo spoke about how his team’s play leading up to the deadline would determine whether the front office would operate as buyers or sellers. The Nats have gone 1-4 since those comments, including a loss to the last-place Marlins and a three-game sweep at the hands of the Orioles in Baltimore.
There’s no indication yet that the Nationals are on the brink of a broad-reaching sell-off, but Chelsea Janes of the Washington Post reports that the Nationals are receiving “a lot” of interest in All-Star shortstop Trea Turner and have not firmly ruled out moving him (Twitter thread). It goes without saying that the Nats would need an overwhelming return in order to part with Turner, who is still owed about $4.82MM of this year’s $13MM salary and is controlled via arbitration through the 2022 season.
Broadly speaking, one would think that the 28-year-old Turner is an extension candidate more than a trade candidate, given the Nationals’ perennially high payroll, recent World Series victory and general “win-now” mindset. However, MLB Network’s Peter Gammons tweeted today that Nationals ownership doesn’t have plans to green-light a long-term extension with Turner.
Absence of an extension doesn’t necessarily mean that a trade of Turner is a foregone conclusion, of course. The Nationals will in all likelihood be aiming to contend in 2022, regardless of how their 2021 campaign plays out, and Turner would be a central figure in those efforts. But it’s also certainly possible that for a player of Turner’s caliber, the Nats could extract multiple near-MLB pieces and/or controllable young big leaguers who could both deepen the roster for the 2022 season and set them up nicely in the long run.
Turner, the No. 13 overall pick back in 2014, has established himself as one of MLB’s best all-around talents dating back to a breakout 2016 campaign. He’s a .301/.356/.489 hitter 92 home runs and 190 stolen bases in that time and, in deserving fashion, finally nabbed his first All-Star nod in 2021. Turner is batting .319/.367/.521 this season and entered play leading the National League with 199 total bases on the season. No one has swiped more bases than Turner since the start of the 2016 season, and FanGraphs ranks him 20th among all position players in wins above replacement in that span.
If Turner indeed were to hit the market, it’d be a major shakeup to a fairly limited crop of available infielders. Fellow shortstops Trevor Story and Javier Baez are the most notable player available, though neither is having a great year at the plate. Other (non-shortstop) possibilities include Jonathan Schoop, Eduardo Escobar, Whit Merrifield and Asdrubal Cabrera. Story has reportedly received some interest as a possible outside-the-box option in center field, and Turner could hold similar appeal — particularly since he’s actually played 387 innings of center field in the big leagues. (Story has played only shortstop in the Majors.)
The market for infield help is still developing — as is the trade market in general, despite the deadline’s proximity — but the Mariners, Brewers, Mets, Reds, White Sox, A’s have all been linked to infield upgrades (not necessarily at shortstop). The Padres, who originally drafted Turner, seem to be in on virtually every big name that hits the market, regardless of whether their roster presents a clear fit.
The Turner rumblings come at the same time as reports that Max Scherzer is at least open to waiving his 10-and-5 no-trade rights. While that doesn’t definitively signal the organization has made up its mind to sell this week, but it’s only natural to think that after slipping in recent weeks — or at least failing to gain much ground — hopeful buyers are beginning to circle and gauge the asking prices should the Nats eventually wave the white flag on 2021. Rizzo himself last week said that if the Nats do become sellers, “everything will be on the table, I would think.”